(NASDAQ: WGS) Genedx Holdings's forecast annual revenue growth rate of 20.36% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 7.75%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.06%.
Genedx Holdings's revenue in 2026 is $442,678,000.On average, 11 Wall Street analysts forecast WGS's revenue for 2026 to be $14,798,887,699, with the lowest WGS revenue forecast at $13,735,462,572, and the highest WGS revenue forecast at $17,297,728,932. On average, 11 Wall Street analysts forecast WGS's revenue for 2027 to be $18,519,688,123, with the lowest WGS revenue forecast at $16,609,857,346, and the highest WGS revenue forecast at $22,765,372,864.
In 2028, WGS is forecast to generate $23,081,253,471 in revenue, with the lowest revenue forecast at $19,196,278,258 and the highest revenue forecast at $27,457,565,531.